Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::

余文鍾 (Wen-Chung Yu)

[簡介]

  • 學歷
    國立陽明大學醫學系畢業
  • 經歷
    現職:
    • - 迄今 國立陽明交通大學 醫學系 副教授
    • - 迄今 臺北榮民總醫院 內科部心臟內科 主治醫師
    經歷:
    • - 竹東榮民醫院 內科 住院醫師
    • - 臺北榮民總醫院 內科部 住院總醫師
  • 醫療專長
    1. 成人心臟內科 心臟超音波 Echocardiography 電氣生理 Electrocardiography
  • 證照
    中華民國內科專科醫師 中華民國心臟專科醫師

[著作]

  1. Chien Y, Chou SJ, Chang YL, Leu HB, Yang YP, Tsai PH, Lai YH, Chen KH, Chang WC, Sung SH and Yu WC. Inhibition of Arachidonate 12/15-Lipoxygenase Improves alpha-Galactosidase Efficacy in iPSC-Derived Cardiomyocytes from Fabry Patients. Int J Mol Sci. 2018;19(5):1480.
  2. Huang WM, Lin YP, Chen CH and Yu WC. Tissue Doppler imaging predicts outcomes in hemodialysis patients with preserved left ventricular function. J Chin Med Assoc. 2019;82:351-355.
  3. Wang WT, Sung SH, Liao JN, Hsu TR, Niu DM and Yu WC. Cardiac manifestations in patients with classical or cardiac subtype of Fabry disease. J Chin Med Assoc. 2020;83:825-829.
  4. Lu DY, Huang WM, Wang WT, Hung SC, Sung SH, Chen CH, Yang YJ, Niu DM and Yu WC. Reduced global longitudinal strain as a marker for early detection of Fabry cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2022;23:487-495.
  5. Hung CL, Wu YW, Lin CC, Lai CH, Jyh-Ming Juang J, Chao TH, Kuo L, Sung KT, Wang CY, Wang CL, Chu CY, Yu WC and Hou CJ. 2021 TSOC Expert Consensus on the Clinical Features, Diagnosis, and Clinical Management of Cardiac Manifestations of Fabry Disease. Acta Cardiol Sin. 2021;37:337-354.

 限於篇幅,以上謹為代表著作

回到最上